2025年7月17日，寧波三生生物科技股份有限公司（簡稱“寧波三生生物”）與列日大學(xué)（A·范德普拉斯肯教授實(shí)驗(yàn)室）簽署合作協(xié)議，共同研發(fā)針對鰻魚皰疹病毒1型（AngHV-1）的有效疫苗。鰻魚作為中國水產(chǎn)養(yǎng)殖業(yè)的重要品種，深受消費(fèi)者青睞。然而該病毒正在中國福建、廣東等主要鰻魚養(yǎng)殖區(qū)傳播，對鰻魚產(chǎn)業(yè)構(gòu)成重大威脅。研究表明，該病毒可導(dǎo)致高達(dá)60%的死亡率，給鰻魚養(yǎng)殖行業(yè)帶來巨大經(jīng)濟(jì)損失。為遏制疾病傳播并保障高產(chǎn)養(yǎng)殖業(yè)的健康安全，亟需研發(fā)有效疫苗。寧波三生生物與列日大學(xué)科研團(tuán)隊(duì)攜手響應(yīng)市場需求，共同推進(jìn)疫苗研發(fā)工作。安德普拉斯肯教授實(shí)驗(yàn)室的研究工作獲得比利時(shí)韋爾生物研究所（項(xiàng)目編號(hào)WELBIO-CR-2022 A-14 12)及歐洲海洋與漁業(yè)基金（Eel4ever）的資助支持。 鰻魚健康養(yǎng)殖工程是寧波三生生物預(yù)防和管理水產(chǎn)養(yǎng)殖病害戰(zhàn)略的重要組成部分。

On July 17th, 2025, the Ningbo Sansheng BiotechnologyCo. Ltd （Sansheng）and the University of Liège (Laboratory of Prof. A. Vanderplasschen) signed an agreement to jointly develop an effective vaccine against Anguillid herpesvirus 1 (AngHV-1). Eel is one of the major aquaculture fish species in China and the eel is widely liked by consumers.  However, AngHV-1 is circulating and posing a high threat to this species. The virus was detected and reported in major eel production areas of China such as Fujian and Guangdong. It can cause mortalities up to 60%, leading to very high economic losses to this industry.

An effective vaccine is needed to curb the disease and provide health assurance for high productivity.  Ningbo Sansheng Biotechnology Co. Ltd and University of Liège scientific team have committed to join hands to answer the call and develop this vaccine. Researches activities of the laboratory of Prof. A. Vanderplasschen are supported by the Wel Research Institute (WELBIO-CR-2022 A-14 12) and the European Maritime and Fisheries Fund (Eel4ever) (Belgium).  

The eel safeguarding project is an important part to fullfill Sansheng’s strategy to guard against aquaculture diseases.